BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19016016)

  • 21. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
    Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
    Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated fractionation head and neck intensity-modulated radiation therapy and concurrent chemotherapy in the community setting: safety and efficacy considerations.
    Monroe AT; Young JA; Huff JD; Ernster JA; White GA; Peddada AV
    Head Neck; 2009 Sep; 31(9):1144-51. PubMed ID: 19340861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
    Gomez DR; Zhung JE; Gomez J; Chan K; Wu AJ; Wolden SL; Pfister DG; Shaha A; Shah JP; Kraus DH; Wong RJ; Lee NY
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1096-103. PubMed ID: 18707827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma.
    Hoebers FJ; Heemsbergen W; Balm AJ; van Zanten M; Schornagel JH; Rasch CR
    Radiother Oncol; 2007 Oct; 85(1):42-7. PubMed ID: 17445927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.
    Li X; Di B; Shang Y; Zhou Y; Cheng J; He Z
    Eur J Surg Oncol; 2009 Dec; 35(12):1348-53. PubMed ID: 19616915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population.
    Airoldi M; Gabriele AM; Garzaro M; Raimondo L; Condello C; Beatrice F; Pecorari G; Giordano C
    Radiother Oncol; 2009 Jul; 92(1):105-10. PubMed ID: 19264368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
    Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
    Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential nephrotoxic effects of intensity modulated radiotherapy delivered to the para-aortic area of women with gynecologic malignancies: preliminary results.
    Varlotto JM; Gerszten K; Heron DE; Comerci J; Gautam S; Selvaraj R; Lalonde R; Chura JC
    Am J Clin Oncol; 2006 Jun; 29(3):281-9. PubMed ID: 16755182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma.
    Hosni A; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; De Almeidad J; O'Sullivan B; Goldstein D; Hope A
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):368-375. PubMed ID: 28033442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.
    Monroe AT; Reddy SC; Gibbs GL; White GA; Peddada AV
    Radiother Oncol; 2008 May; 87(2):188-94. PubMed ID: 18237801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyfra 21-1 in diagnosis of distant metastases of head and neck carcinoma.
    Hoffmann-Fazel A; Hoffmann M; Gottschlich S; Maass JD; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):917-20. PubMed ID: 12820323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
    Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
    Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.
    Studer G; Rordorf T; Glanzmann C
    Radiat Oncol; 2011 Sep; 6():120. PubMed ID: 21936952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.